These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Risk of relapse in leprosy after fixed-duration multidrug therapy. Li HY, Hu LF, Huang WB, Liu GC, Yuan LC, Jin Z, Li X, Li JL, Yang ZM. Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597 [Abstract] [Full Text] [Related]
9. Relapse rates amongst the multidrug therapy-treated leprosy patients. Umarane SB. Indian J Lepr; 2001 Jun; 73(4):362-4. PubMed ID: 11898471 [No Abstract] [Full Text] [Related]
10. Workshop on multidrug therapy of leprosy in low-endemic areas: an evaluation. Indian J Lepr; 1991 Jun; 63(1):132-5. PubMed ID: 1919083 [No Abstract] [Full Text] [Related]
11. Chemotherapy of leprosy. Report of a WHO Study Group. World Health Organ Tech Rep Ser; 1994 Jun; 847():1-24. PubMed ID: 7817604 [No Abstract] [Full Text] [Related]